GMRE Global Medical REIT Inc
- 9.795
- +0.165+1.71%
Global Medical REIT Inc News
Global Medical REIT Analyst Ratings
B. Riley Securities Adjusts Global Medical REIT's Price Target to $10 From $11, Keeps Buy Rating
Global Medical REIT: A Balanced Outlook With Hold Rating Amidst Tenant Challenges and Strategic Acquisitions
Analysts Offer Insights on Real Estate Companies: Global Medical REIT (GMRE) and Douglas Emmett (DEI)
Global Medical REIT: A Cautious Hold Amid Balanced Risk-Reward Profile
JMP Securities Reaffirms Their Hold Rating on Global Medical REIT (GMRE)
Stable Occupancy and Strategic Investment Fuel Buy Rating for Global Medical REIT
Positive Outlook for Global Medical REIT Amid Market Uncertainty: A Buy Recommendation
Analysts Have Conflicting Sentiments on These NA Companies: Global Medical REIT (GMRE), PulteGroup (PHM) and RealReal (REAL)
Analysts Offer Insights on NA Companies: Global Medical REIT (GMRE), Invesco Mortgage (IVR) and Re/Max Holdings (RMAX)
Analysts Offer Insights on NA Companies: Ryman (RHP), Extra Space Storage (EXR) and Global Medical REIT (GMRE)
Analysts Offer Insights on NA Companies: MGM Resorts (MGM) and Global Medical REIT (GMRE)
Analysts Offer Insights on NA Companies: Global Medical REIT (GMRE) and Simon Property (SPG)
Analysts' Top Financial Picks: Global Medical REIT (GMRE), JPMorgan Chase & Co. (JPM)
B. Riley Securities Maintains Buy on Global Medical REIT, Lowers Price Target to $11
B. Riley Trims Global Medical REIT's Price Target to $11 From $12 After Q1 Results Missed Expectations, Keeps Buy Rating
Analysts Offer Insights on Financial Companies: Global Medical REIT (GMRE) and ANZ Group Holdings (OtherANZGF)
BMO Capital Keeps Their Hold Rating on Global Medical REIT (GMRE)
B. Riley Securities Maintains Buy on Global Medical REIT, Lowers Price Target to $12
B. Riley Lowers Global Medical REIT's Price Target to $12 From $14 After Q4 Results Missed Expectations, Keeps Buy Rating
Analysis
Price Target
No Data
